India's Cipla Q3 net up 25.5 pct

MUMBAI Wed Feb 6, 2013 5:01pm IST

Stocks

   

MUMBAI Feb 6 (Reuters) - Cipla Ltd, India's fifth largest drugmaker by sales, reported a 25.5 percent rise in quarterly profit on robust sales but slightly missed street estimates as taxes surged.

The Mumbai-based drugmaker said, net profit grew to 3.39 billion rupees ($63.81 million) in October-December from 2.7 billion rupees a year earlier. Analysts on an average had expected a net profit of 3.48 billion rupees, according to Thomson Reuters I/B/E/S.

Sales rose 18.65 percent to 20.3 billion rupees, it said.

Shares in Cipla fell 0.56 percent to 405 rupees on Wednesday when the Mumbai market closed down 0.1 percent. ($1 = 53.12 rupees) (Reporting by Kaustubh Kulkarni; Editing by Anand Basu)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

REUTERS SHOWCASE

Indian Markets

Indian Markets

Nifty marks record high, tracks higher global shares.  Full Article 

Tracking Asia

Tracking Asia

Asian shares hitch a ride on Wall Street's record  Full Article 

Commodities

Commodities

Gold near two-month low; set for weekly drop on interest rate fears  Full Article 

RBI Annual Report

RBI Annual Report

RBI reiterates commitment to bring down inflation .  Full Article 

Monsoon Update

Monsoon Update

Monsoon to display lull as floods ease.  Full Article 

Regulatory Troubles

Regulatory Troubles

U.S. regulator alleges Dr Reddy's breached packaging rules  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage